COSTA MESA, Calif., Nov. 19, 2018 /PRNewswire-PRWeb/ --áStudyKIK, a patient recruitment company headquartered in
"StudyKIK is very excited about this vital communication tool and our mobile and tablet strategy," states StudyKIK Chief Technology Officer Stace Baal. "I believe this app will ease the burden on research sites to quickly and effectively communicate with patients. The faster sites are able to facilitate patient visits and answer their questions, the more patients will be able to participate in potentially life altering trials."
Since its inception, StudyKIK has made it a goal to simplify the research site's workload when it comes to patient communication. The new Patient Messenger App does just that, allowing sites to send and receive text messages, as well as manage inbound/outbound messages through the StudyKIK Portal - all while on the go. StudyKIK has built this mobile app for research sites after a great deal of research has shown that over 82% of patients enrolled in clinical trials prefer to communicate through text messaging. The app allows the research sites the ability to communicate to the patient through a text message but the patient does not have to have the app as they can use their normal phone provider's text message service.
By continuously striving to be the most reliable and innovative patient recruitment provider in the industry, this new offering is another step toward StudyKIK's goal of helping patients and bringing new technologies to the clinical trial industry as fast as possible.
To get started, Download for Free today on both Apple App Store or Android by searching for "StudyKIK" in the app store.
*Research sites can login to the StudyKIK Messenger App with their usual StudyKIK login information.
More About StudyKIK:
StudyKIK utilizes social media to provide disruptive patient recruiting solutions for clinical trial sites, clinical research organizations, and pharmaceutical companies. The Company is a first mover in the patient recruitment space, using social media to address recruiting and retention of patients in the $40bn+ clinical trial industry that has historically relied on traditional advertising mediums such as print and radio. StudyKIK serves over 1,600 research sites with a growing database of over 2,000,000 patients from its extensive social media communities across Facebook, Instagram, Snapchat, Twitter, and Pinterest.
Subscribe to our Free Newsletters!